摘要
自从sirtuins 在无数病理过程中发挥调节作用以来,人们对它们产生了浓厚的研究兴趣。在过去的二十年中,许多研究工作致力于开发 Sirtuin 调节剂。尽管合成 Sirtuin 调节剂是重点,但天然调节剂仍然是该领域有待进一步探索的一个组成部分,因为它们被发现具有治疗各种疾病的潜力,包括癌症、神经退行性疾病和代谢紊乱。由于这组化合物的重要性,本综述就天然存在的沉默调节蛋白调节剂、相关分子机制及其治疗益处给出了当前的立场。此外,通过全面的数据挖掘,对 2010-2020 年 Sirtuin 调节剂的发展趋势进行了详细的统计数据分析。最后,还将讨论天然sirtuin 调节剂在药物发现中的挑战和未来前景。
关键词: Sirtuins、天然产物、调节剂、药物发现、抑制剂、激活剂。
Current Medicinal Chemistry
Title:Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Volume: 28 Issue: 37
关键词: Sirtuins、天然产物、调节剂、药物发现、抑制剂、激活剂。
摘要: There have been intense research interests in sirtuins since the establishment of their regulatory roles in a myriad of pathological processes. In the last two decades, many research efforts have been dedicated to the development of sirtuin modulators. Although synthetic sirtuin modulators are the focus, natural modulators remain an integral part to be further explored in this area as they are found to possess therapeutic potential in various diseases, including cancers, neurodegenerative diseases, and metabolic disorders. Owing to the importance of this cluster of compounds, this review gives a current stand on the naturally occurring sirtuin modulators, associated molecular mechanisms, and their therapeutic benefits. Furthermore, comprehensive data mining resulted in detailed statistical data analysis pertaining to the developmental trend of sirtuin modulators from 2010-2020. Lastly, the challenges and future prospects of natural sirtuin modulators in drug discovery will also be discussed.
Export Options
About this article
Cite this article as:
Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020), Current Medicinal Chemistry 2021; 28 (37) . https://dx.doi.org/10.2174/0929867328666210329124415
DOI https://dx.doi.org/10.2174/0929867328666210329124415 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiproliferative Activity of Cobra Venom Cytotoxins
Current Topics in Medicinal Chemistry The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology Cartilage and Bone Extracellular Matrix
Current Pharmaceutical Design The Functions of Histone Modification Enzymes in Cancer
Current Protein & Peptide Science Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis
Drug Design Reviews - Online (Discontinued) Paeonol Inhibits Migration, Invasion and Bone Adhesion of Small Cell Lung Cancer Cells
Current Signal Transduction Therapy Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Anti-Cancer Agents in Medicinal Chemistry Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Current Gene Therapy Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight
Recent Patents on Biotechnology Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design The Key Role of Canonical Wnt/β-catenin Signaling in Cartilage Chondrocytes
Current Drug Targets Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry The Role of MDCT in Craniocervical Junction Pathologies: Pictorial Review
Current Medical Imaging The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Recent Patents on Anti-Cancer Drug Discovery Complications of Muscle Hematomas in Hemophilia
Cardiovascular & Hematological Disorders-Drug Targets Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets